Rizo Aleksandra
Syndax Pharmaceuticals, Inc. · Director
Rizo Aleksandra is listed in filings as Director at Syndax Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Feb 6, 2026, including 2 public disclosures. Recent filings connect the profile to Syndax Pharmaceuticals, Inc. (SNDX). The current snapshot covers public activity from Feb 7, 2025 to Feb 6, 2026. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||